ABSTRACT
Calcific aortic stenosis is not the result of decades of wear and tear alone. Rather, it is being increasingly recognized as an inflammatory, atheromatous, and potentially modifiable disease. Exciting new research suggests that medical therapies may soon be available to retard its progression and reduce the need for surgery.
Footnotes
↵* The author has indicated that he has received grant or research support from Pfizer Inc.
† The author has indicated that he is on the speakers’ bureau of the Merck corporation and has received grant or research support from Pfizer Inc.
- Copyright © 2003 The Cleveland Clinic Foundation. All Rights Reserved.